MRC-5 Cell Avalanche® Transfection Reagent is a new, proprietary solution specifically designed for transfection on MRC-5 cells. The proprietary formulation of lipids and polymers ensures the highest possible transfection efficiencies and viabilities for MRC-5 cells. No other transfection reagents can match the efficiency, convenience, and gentleness of MRC-5 Cell Avalanche® Transfection Reagent for transfection on MRC-5 cells. For details of the developing process of this reagent, please go to: How did EZ Biosystems develop Avalanche® Cell type/cell line specific transfection reagent series?
The MRC-5 cell line was derived from normal lung tissue of a 14-week-old male fetus by J.P. Jacobs in September of 1966. The cells are capable of 42 to 46 population doublings before the onset of senescence.
Features of The Transfection Reagent:
Broad spectrum for the transfection of large plasmid, mRNA, siRNA, and/or other type of nucleic acids, which is best for co-transfection of different type and/or size of nucleic acids.
Specifically optimized to deliver nucleic acids into MRC-5 cells
Highest efficiency to ensure experimental success
Lowest Cellular Toxicity-maintain cell density and reduce experimental biases
0.5 ml is able to transfect about 1000 wells of 24-well plate
Synthesized from 100% animal origin-free components, making it easy to validate the absence of zoonotic diseases, such as BSE or viruses, in research experiments or cells lines
Compatible with serum
Developed and manufactured by EZ Biosystems
Data
FIG. 1. High throughput test of transfection efficiency (determined as RLU/mg) on WI-38 cells after transfection of luciferase reporter gene by using our 172 proprietary transfection formulas and several most popular commercial transfection reagents. The yellow box showed the results of 4 commercial transfection reagents. The red lines marked our candidate formulas with the highest transfection efficiency for WI-38 cells. This test result was confirmed with repeat experiments. The candidate formulas were also tested in MRC-5 cells by transfecting GFP expression plasmid, and got the same high transfection efficiency after flow cytometry analysis. The one that showed the optimal balance of potent & low cytotoxicity (percentage of 7AAD positive cells) among those candidate formulas was later named as MRC-5 Cell Avalanche Transfection Reagent.
For Other Cells
MRC-5 Cell Avalanche® Transfection Reagent can also be used on the following cells with high transfection efficiencies.
Caki-1 Cell
MDCK Cell
293 Cell
WI-38 Cell
COS-7 Cell
BHK-21 Cell
3197-3 Cell
NIH/3T3 Cell
Recommended protocols for these cells will be provided with the reagent. The protocols usually provide satisfactory transfection efficiency with invisible cytotoxicity. However, optimization may be needed for certain type of cells. Optimizations may include: the amount of DNA and this transfection reagent; cell density; transfection reagent/DNA ratio, or incubation time for the mixture of transfection reagent/DNA etc. For best transfection result, we recommend using the respective cell type/cell line specific Avalanche transfection reagents. Those reagents have been optimized on both recipes and protocols, and have been proved to have the best transfection results for the respective cell lines or primary cells. You can easily find the respective Avalanche transfection reagents specific for your cells by using the filters of our product list.
Additional Information
Weight
0.5 lbs
Adherence Phenotype
Adherent
Cell Type
Fibroblast
Disease
Healthy
Names starting from
M
Primary/Cell Line
Cell Line
Product Sizes
0.5 ml, 1.5 ml
Species
Human
Tissue Sources
Lung
Subcategories
Cell Type/Cell Line Specific
Documents
Protocols
EZT-MRC5-1 Protocol.
MSDS
EZT-MRC5-1 MSDS
Citations or Feedback
Goullet de Rugy, T., Bashkurov, M., Datti, A., Betous, R., Guitton-Sert, L., Cazaux, C., . . . Hoffmann, J. S. (2016). Excess Poltheta functions in response to replicative stress in homologous recombination-proficient cancer cells. Biol Open, 5(10), 1485-1492. doi:10.1242/bio.018028
Lear, T., McKelvey, A. C., Rajbhandari, S., Dunn, S. R., Coon, T. A., Connelly, W., . . . Chen, B. B. (2016). Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4. J Exp Med, 213(6), 1029-1046. doi:10.1084/jem.20151229
The MRC-5 cell line was derived from normal lung tissue of a 14-week-old male fetus by J.P. Jacobs in September of 1966. The cells are capable of 42 to 46 population doublings before the onset of senescence.
Features of The Transfection Reagent:
Broad spectrum for the transfection of large plasmid, mRNA, siRNA, and/or other type of nucleic acids, which is best for co-transfection of different type and/or size of nucleic acids.
Specifically optimized to deliver nucleic acids into MRC-5 cells
Highest efficiency to ensure experimental success
Lowest Cellular Toxicity-maintain cell density and reduce experimental biases
0.5 ml is able to transfect about 1000 wells of 24-well plate
Synthesized from 100% animal origin-free components, making it easy to validate the absence of zoonotic diseases, such as BSE or viruses, in research experiments or cells lines
Compatible with serum
Developed and manufactured by EZ Biosystems
Data
FIG. 1. High throughput test of transfection efficiency (determined as RLU/mg) on WI-38 cells after transfection of luciferase reporter gene by using our 172 proprietary transfection formulas and several most popular commercial transfection reagents. The yellow box showed the results of 4 commercial transfection reagents. The red lines marked our candidate formulas with the highest transfection efficiency for WI-38 cells. This test result was confirmed with repeat experiments. The candidate formulas were also tested in MRC-5 cells by transfecting GFP expression plasmid, and got the same high transfection efficiency after flow cytometry analysis. The one that showed the optimal balance of potent & low cytotoxicity (percentage of 7AAD positive cells) among those candidate formulas was later named as MRC-5 Cell Avalanche Transfection Reagent.
For Other Cells
MRC-5 Cell Avalanche® Transfection Reagent can also be used on the following cells with high transfection efficiencies.
Caki-1 Cell
MDCK Cell
293 Cell
WI-38 Cell
COS-7 Cell
BHK-21 Cell
3197-3 Cell
NIH/3T3 Cell
Recommended protocols for these cells will be provided with the reagent. The protocols usually provide satisfactory transfection efficiency with invisible cytotoxicity. However, optimization may be needed for certain type of cells. Optimizations may include: the amount of DNA and this transfection reagent; cell density; transfection reagent/DNA ratio, or incubation time for the mixture of transfection reagent/DNA etc. For best transfection result, we recommend using the respective cell type/cell line specific Avalanche transfection reagents. Those reagents have been optimized on both recipes and protocols, and have been proved to have the best transfection results for the respective cell lines or primary cells. You can easily find the respective Avalanche transfection reagents specific for your cells by using the filters of our product list.
Additional Information
Weight
0.5 lbs
Adherence Phenotype
Adherent
Cell Type
Fibroblast
Disease
Healthy
Names starting from
M
Primary/Cell Line
Cell Line
Product Sizes
0.5 ml, 1.5 ml
Species
Human
Tissue Sources
Lung
Subcategories
Cell Type/Cell Line Specific
Documents
Protocols
EZT-MRC5-1 Protocol.
MSDS
EZT-MRC5-1 MSDS
Citations or Feedback
Goullet de Rugy, T., Bashkurov, M., Datti, A., Betous, R., Guitton-Sert, L., Cazaux, C., . . . Hoffmann, J. S. (2016). Excess Poltheta functions in response to replicative stress in homologous recombination-proficient cancer cells. Biol Open, 5(10), 1485-1492. doi:10.1242/bio.018028
Lear, T., McKelvey, A. C., Rajbhandari, S., Dunn, S. R., Coon, T. A., Connelly, W., . . . Chen, B. B. (2016). Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4. J Exp Med, 213(6), 1029-1046. doi:10.1084/jem.20151229